Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
- PMID: 11099445
- DOI: 10.1093/brain/123.12.2423
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence
Erratum in
- Brain 2001 Jun;124(Pt 6):1258
Abstract
Iron content of the basal ganglia was investigated in 25 patients with idiopathic Parkinson's disease and 14 matched healthy control subjects using a partially refocused interleaved multiple echo sequence on a 1.5 Tesla MRI system. R(2)* (1/T(2)*) and R(2)' (1/T(2)') relaxation rates were higher in the substantia nigra of patients with Parkinson's disease, which indicates that iron content is elevated in this region. R(2)' was lower in the putamen, indicating reduced iron levels; reduction in this region was positively correlated with disease duration. Iron-related oxidative stress may contribute to the neurodegeneration of Parkinson's disease, which may lead to alterations in the iron levels of the striatum. We describe a simple, non-invasive technique for measuring iron content.
Similar articles
-
Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.PLoS One. 2012;7(4):e35397. doi: 10.1371/journal.pone.0035397. Epub 2012 Apr 17. PLoS One. 2012. PMID: 22530017 Free PMC article.
-
Quantitative Susceptibility Mapping in Parkinson's Disease.PLoS One. 2016 Sep 6;11(9):e0162460. doi: 10.1371/journal.pone.0162460. eCollection 2016. PLoS One. 2016. PMID: 27598250 Free PMC article.
-
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24. Brain. 2011. PMID: 21109502
-
Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Neurosci Bull. 2017 Oct;33(5):561-567. doi: 10.1007/s12264-017-0138-x. Epub 2017 May 17. Neurosci Bull. 2017. PMID: 28516282 Free PMC article. Review.
-
What process causes nigral cell death in Parkinson's disease?Neurol Clin. 1992 May;10(2):387-403. Neurol Clin. 1992. PMID: 1584181 Review.
Cited by
-
Modeling ferroptosis in human dopaminergic neurons: Pitfalls and opportunities for neurodegeneration research.Redox Biol. 2024 Jul;73:103165. doi: 10.1016/j.redox.2024.103165. Epub 2024 Apr 24. Redox Biol. 2024. PMID: 38688061 Free PMC article.
-
Oxytosis/Ferroptosis in Neurodegeneration: the Underlying Role of Master Regulator Glutathione Peroxidase 4 (GPX4).Mol Neurobiol. 2024 Mar;61(3):1507-1526. doi: 10.1007/s12035-023-03646-8. Epub 2023 Sep 19. Mol Neurobiol. 2024. PMID: 37725216 Review.
-
Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson's disease with freezing of gait.Front Aging Neurosci. 2023 Feb 2;15:1060935. doi: 10.3389/fnagi.2023.1060935. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36819729 Free PMC article.
-
Curcumin and N-Acetylcysteine Nanocarriers Alone or Combined with Deferoxamine Target the Mitochondria and Protect against Neurotoxicity and Oxidative Stress in a Co-Culture Model of Parkinson's Disease.Antioxidants (Basel). 2023 Jan 5;12(1):130. doi: 10.3390/antiox12010130. Antioxidants (Basel). 2023. PMID: 36670992 Free PMC article.
-
The different facets of heme-oxygenase 1 in innate and adaptive immunity.Cell Biochem Biophys. 2022 Dec;80(4):609-631. doi: 10.1007/s12013-022-01087-z. Epub 2022 Aug 26. Cell Biochem Biophys. 2022. PMID: 36018440 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical